Correlation of Hyaluronic Acid (HA), Syndecan-1 (SDC-1), Heparan Sulfate (HS) with early stage ad organ dysfunction in sepsis patients [0.03%]
透明质酸(HA)、 syndecan-1(SDC-1)及肝素硫酸盐(HS)与脓毒症早期器官功能障碍的相关性分析
Zhengchao Li,Xingpeng Jiang,Jinghui Li et al.
Zhengchao Li et al.
This study aimed to explore the relationship between the changes in early degradation products of polysaccharide coatings (such as hyaluronic acid (HA), syndecan-1 (SDC-1), and heparan sulfate (HS)) and the development of organ dysfunction ...
Optimizing Digoxin Use for Rate Control in Critically Ill Patients with Atrial Arrhythmias: Lessons from a Retrospective Study [0.03%]
危重病人心房心律失常患者中控制心室率的洋地黄用药优化：一项回顾性研究的经验教训
Marco Giuseppe Del Buono,Simone Filomia,Tommaso Sanna
Marco Giuseppe Del Buono
IL-1 blockade in myocardial infarction and its efficacy in patients with complex coronary artery disease. Another brick in the wall [0.03%]
心肌梗死中的白细胞介素-1抑制及其在复杂冠状动脉疾病患者中的疗效：另一块墙砖
M Sadler,C Madaudo,A Cannata et al.
M Sadler et al.
Efficacy and safety of Treating Pulmonary Arterial Hypertension With Imatinib:A meta-analysis of randomized controlled trials [0.03%]
伊马替尼治疗肺动脉高压的有效性和安全性：随机对照试验的 Meta 分析
Xiaofa Chen,Lina Xu,Bijuan Xue
Xiaofa Chen
Pulmonary vascular remodeling and arterial hypertension (PAH) correlate to increased platelet-derived growth factor (PDGF) activity and elevated KIT expression. Imatinib has emerged as a potential therapeutic agent for PAH. The purpose of t...
Advances in studying the pathological mechanisms and treatment strategies of transthyretin amyloidosis [0.03%]
转甲状腺素蛋白淀粉样变性病理机制及治疗策略的研究进展
Hongyin Chen,Ruonan Liu,Siqi Luo et al.
Hongyin Chen et al.
Transthyretin amyloidosis (ATTR) is characterized by the deposition of unstable transthyretin protein (TTR) in the heart or peripheral nerves. Therapeutic strategies for ATTR include inhibition of the secretion of abnormal TTR by the liver,...
Predicting vulnerability status of carotid plaques using CTA-based quantitative analysis [0.03%]
基于CTA的定量化分析预测颈动脉斑块的易损性
Qun Lao,Rongzhen Zhou,Yitian Wu et al.
Qun Lao et al.
The study aimed to develop a radiomics model to assess carotid artery plaque vulnerability using CTA images. It retrospectively included 107 patients with carotid artery stenosis who underwent carotid artery stenting (CAS) from 2017 to 2022...
Sodium glucose cotransporter 2 inhibitors improve long-term atrial fibrillation-free survival after catheter ablation [0.03%]
钠葡萄糖协同转运蛋白2抑制剂改善导管消融后长期无房颤生存率
Aykun Hakgor,Fatih Erkam Olgun,Atakan Dursun et al.
Aykun Hakgor et al.
Although sodium-glucose cotransporter-2 inhibitors (SGLT2i) are known to reduce the incidence of atrial fibrillation (AF) and AF-related adverse events, evidence on their prognostic effect in patients undergoing catheter ablation (CA) for A...
Drug-induced Spontaneous intramural hematoma of the gastrointestinal tract: A real-world pharmacovigilance analysis [0.03%]
药物所致胃肠黏膜下自发性血肿的信号检测及关联分析：一项基于真实世界用药安全性的研究
Xuehong Wang,Min Luo,Wenyu Li et al.
Xuehong Wang et al.
It is unclear whether drugs other than warfarin can cause spontaneous gastrointestinal intraluminal hematomas (SGIH). This study aimed to investigate the drugs that induced SGIH based on the FDA Adverse Event Reporting System (FAERS) data. ...
Drug Interaction of SGLT2Is and ARNI on Acute Kidney Injury: A Real-world Pharmacovigilance Analysis Through the FAERS [0.03%]
基于FAERS的SGLT2抑制剂和ARNI联用导致急性肾损伤的药物相互作用：真实世界下的药物流行病学分析
Subei Zhao,Ronghua He,Mei Mei et al.
Subei Zhao et al.
Sodium-glucose cotransporter 2 inhibitors (SGLT2Is) and angiotensin receptor-neprilysin inhibitor (ARNI) may cause potential renal damage, the combined impact of SGLT2Is and ARNI on acute kidney injury (AKI) remains unclear. This pharmacovi...
Mineralocorticoid receptor antagonist vs. placebo in a patient with end-stage kidney disease under renal replacement therapy: a systematic review and meta-analysis [0.03%]
终末期肾病替代治疗患者使用盐皮质激素受体拮抗剂与安慰剂的系统性回顾和meta分析
Sagun Dawadi,Dhan Bahadur Shrestha,Prakash Raj Oli et al.
Sagun Dawadi et al.
The number of patients living with chronic kidney diseases is increasing, and so are the patients with end-stage renal disease (ESRD) undergoing renal replacement therapy (RRT). While there is a common understanding that these patients face...